Challenges and opportunities to integrating family members of injection drug users into harm reduction efforts within the Atlantic Canadian context

International Journal of Drug Policy

Volumn 22, Issue 5, 2011, Pages 385-392

  Jackson, Lois A ^a,b   Dykeman, Margaret ^c   Gahagan, Jacqueline ^a   Karabanow, Jeff ^a   Parker, Joanne ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b Atlantic Health Promotion Research Centre   (Canada)

^c UNIVERSITY OF NEW BRUNSWICK   (Canada)

Author keywords

Atlantic Canada; Family members; Harm reduction practises; Injection drug use; Qualitative research

Indexed keywords

ADULT; ARTICLE; CANADA; CAREGIVER SUPPORT; DRUG DEPENDENCE; EMOTIONALITY; FAMILY COUNSELING; FAMILY RELATION; FEMALE; FRIEND; HOUSING; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RISK REDUCTION; RURAL AREA; SELF CARE; SOCIAL INTERACTION; URBAN AREA;

ADULT; CANADA; DRUG USERS; ECONOMIC RECESSION; FAMILY; FEMALE; FINANCIAL SUPPORT; HARM REDUCTION; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MIDDLE AGED; RURAL POPULATION; SOCIAL SUPPORT; SUBSTANCE ABUSE, INTRAVENOUS; URBAN POPULATION; YOUNG ADULT;

EID: 80052959452     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2011.05.011     Document Type: Article

References (54)

1. Barker J., Hunt G. Representations of family: A review of the alcohol and drug literature. The International Journal of Drug Policy 2004, 15:347-356.
2. Blake, R. B. (2003). Regional and rural development strategies in Canada: The search for solutions. Research Papers for the Royal Commission on renewing and strengthening our place in Canada. St. John's, NF: Government of Newfoundland and Labrador (March).
3. Bungay V., Johnson J., Varcoe C., Boyd S. Women's health and use of crack cocaine in context: Structural and 'everyday' violence. International Journal of Drug Policy 2010, 21:321-329.
4. Candian Centre for Substance Abuse (Canadian HIV/AIDS Legal Network) (2007). Sticking points: Barriers to access to needle and syringe programs in Canada. http://www.aidslaw.ca/publications/publicationsdocEN.php%3Fref=732.
5. CCSA National Policy Working Group Harm reduction: Concepts and practice 1996, Author, Ottawa, ON.
6. Colman R. Women's health in Atlantic Canada: A statistical portrait 2000, Maritime Centre of Excellence for Women's Health, Halifax, NS.
7. Copello A., Velleman R., Templeton L. Family interventions in the treatment of alcohol and drug problems. Drug and Alcohol Review 2005, 24:369-385.
8. Copello A., Templeton L., Velleman R. Family interventions for drug and alcohol misuse: Is there a best practice?. Current Opinion in Psychiatry 2006, 19:271-276.
9. Costenbader E., Astone N., Latkin C. The dynamics of injection drug users' personal networks and HIV risk behaviours. Addiction 2006, 101:1003-1013.
10. Cooper H., Bossak B., Tempalski B., Des Jarlais D., Friedman S. Geographic approaches to quantifying the risk environment: Drug-related law enforcement and access to syringe exchange programmes. International Journal of Drug Policy 2009, 20:217-226.
11. Denning P. Harm reduction therapy with families and friends of people with drug problems. Journal of Clinical Psychology 2010, 66(2):164-174.
12. Dube S., Felitti V., Dong M., Chapman D., Giles W., Anda R. Childhood abuse, neglect and household dysfunction and the risk of illicit drug use: The adverse childhood experiences study. Pediatrics 2003, 111(3):564-572.
13. Fischer B., Rehm J., Brissette S., Brochu S., Bruneau J., El-Guebaly N., et al. Illicit opioid use in Canada: Comparing social, health and drug use characteristics of untreated users in five cities (OPICAN study). Journal of Urban Health 2005, 82(2):250-266.
14. Fischer B., Haydon E., Rehm J., Krajden M., Reimer J. Injection drug use and the hepatitis C virus: Considerations for a targeted treatment approach-The case study of Canada. Journal of Urban Health: Bulletin of the New York Academy of Medicine 2004, 81(3):428-447.
15. Fischer B., Gliksman L., Rehm J., Daniel N., Medved W. Comparing opiate users in methadone treatment with untreated opiate users: Results of a follow-up study with a Toronto opiate user cohort. Canadian Journal of Public Health 1999, 90(5):299-303.
16. Friedman S., deJong W., Rossi D., Touzé G., Rockwell R., DesJarlais D., et al. Harm reduction theory: Users' culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users' groups. International Journal of Drug Policy 2007, 18:107-117.
17. Fontanella B., Turato E. Spontaneous harm reduction: a barrier for substance-dependent individuals seeking treatment?. Review Bras Psiquiatr 2005, 27(4):272-277.
18. Ghodse H., Galea S. Families of people with drug use. Families and mental disorders: From burden to empowerment 2005, 161-193. John Wiley and Sons, Ltd., West Sussex, UK. N. Sartorius, J. Leff, J. Lopez-Ibor, M. Maj, A. Okasha (Eds.).
19. Gustafson D., Goodyear L., Keough F. When the dragon's awake: A needs assessment of people injecting drugs in a small urban centre. International Journal of Drug Policy 2008, 19:189-194.
20. Haggerty K., Skinner M., Fleming C., Gainey R., Catalano R. Long-term effects of the focus on families project on substance use disorders among children of parents in methadone treatment. Addiction 2008, 103:1016-2008.
21. Hamilton M., Barber J.G., Banwell C. Alcohol and other drugs: a family business. Drugs & Alcohol Review 1994, 13(4):371-374.
22. Harocopos A., Goldsamt L., Kobrak P., Jost J., Clatts M. New injectors and the social context of injection initiation. International Journal of Drug Policy 2009, 20:317-323.
23. Higgs P., Jordens J., Maher L., Dunlop A. Vietnamese-Australian heroin users' perspectives on the role of the family in treatment. Drugs: Education, Prevention and Policy 2009, 16(5):409-421.
24. Hope V., Judd A., Hickman M., Lamagni T., Hunter G., Stimson G., et al. Prevalence of Hepatitis C among injection drug users in England and Wales: Is harm reduction working?. American Journal of Public Health 2001, 91(1):38-42.
25. Jackson L., Bailey D., Fraser J., Johnson K., Currie A., Babineau D. Safer and unsafe injection drug use and sex practices among injection drug users in Halifax, Nova Scotia: An exploratory look at community and interpersonal influences. Canadian Journal of Public Health 2002, 93(3):219-222.
26. Jackson L., Parker J., Dykeman M., Gahagan J., Karabanow J. The power of relationships: Implications for safer and unsafe practices among injection drug users. Drugs, Education, Prevention and Policy 2010, 17(3):189-204.
27. Jones L., Pickering L., Sumnall H., McVeigh J., Bellis M. Optimal provision of needle and syringe programmes for injecting drug users: A systematic review. International Journal of Drug Policy 2010, 21:335-342.
28. Kerr, T., Wood, E., Montaner, J., & Tyndall, M. (2009). Findings from the evaluation of Vancouver's pilot medically supervised safer injection facility-Insite (UHRI Report). Vancouver, BC: BC Centre for Excellence in HIV/AIDS, Addiction and Urban Health Research Initiative.
29. Latkin C.A., Hua W., Davey M.A. Factors associated with peer HIV prevention outreach in drug-using communities. AIDS Education and Prevention 2004, 16(6):499-508.
30. Latkin C., Mandell W., Oziemkowska M., Celentano D., Vlahow D., Ensminger M., et al. Using social network analysis to study patterns of drug use among urban drug users at high risk for HIV/AIDS. Drug and Alcohol Dependence 1995, 38:1-9.
31. Leonard L., Forrester L., Navarro C., Hansen J., Doucet C. The effectiveness of needle exchange programmes in modifying HIV-related outcomes: A systematic review of the evidence, 1997-1999 1999, Public Health Branch, Ontario Ministry of Health.
32. Lewandowski C., Hill T. The impact of emotional and material social support on women's drug treatment completion. Health and Social Work 2009, 34(3):213-221.
33. Norrie K., Owram D. A history of the Canadian economy 1996, Harcourt Brace, Toronto.
34. Public Health Agency of Canada Environmental scan of injection drug use, related infectious diseases, high-risk behaviours, and relevant programming in Atlantic Canada 2006, Public Health Agency of Canada Atlantic Regional Office, Halifax, NS.
35. Quigley P. Hard cases in hard places: Challenges of community addictions work in Dublin. Drugs: Education, Prevention and Policy 2003, 10(3):211-221.
36. Rhodes T. Risk environments and drug harms: A social science for harm reduction approach. International Journal of Drug Policy 2009, 20:193-201.
37. Rhodes T. The 'risk environment': A framework for understanding and reducing drug-related harm. International Journal of Drug Policy 2002, 13:85-94.
38. Rhodes T., Watts L., Davies S., Martin A., Smith J., Clark D., et al. Risk, shame and the public injector: A qualitative study of drug injecting in South Wales. Social Science and Medicine 2007, 65:572-585.
39. Ruefli T., Rogers S. How do drug users define their progress in harm reduction programs? Qualitative research to develop user-generated outcomes. Harm Reduction Journal 2004, doi:10. 1186/1477-7517-1-8.
40. Saum C., Hiller M., Leigey M., Inciardi J., Surratt H. Predictors of substance abuse treatment entry for crime involved, cocaine-dependent women. Drug and Alcohol Dependence 2007, 91:253-259.
41. Sherman S., Latkin C. Drug users' involvement in the drug economy: Implications for harm reduction and HIV prevention programs. Journal of Urban Health 2002, 79(2):266-277.
42. Simmonds L., Coomber R. Injecting drug users: A stigmatized and stigmatizing population. International Journal of Drug Policy 2009, 20:121-130.
43. Skerritt J. Manitoba addictions expert quits 2010, Winnipeg Free Press, (May 26, pA3).
44. Stajduhar K., Funk L., Shaw A., Bottorff J., Johnson J. Resilience from the perspective of the illicit injection drug user: An exploratory descriptive study. International Journal of Drug Policy 2009, 20:309-316.
45. Statistics Canada (2010). Canada's population estimates. http://www.statcan.gc.ca/daily-quotidien/101222/dq101222a-eng.htm.
46. Stimson G., O'Hare P. Harm reduction: Moving through the third decade. International Journal of Drug Policy 2010, 21:91-93.
47. Strang J., Best D., Man L.-H., Noble A., Gossop M. Peer-initiated overdose resuscitation: Fellow drug users could be mobilized to implement resuscitation. International Journal of Drug Policy 2000, 11:437-445.
48. Strauss A., Corbin J. Basics of qualitative research: Techniques and procedures for developing grounded theory 1998, Sage Publications, Thousand Oaks.
49. Strike, C., Watson, T., Lavigne, P., Hopkins, S., Shore, R., Young, D., et al Guidelines for better harm reduction: Evaluating implementation of best practice recommendations for needle and syringe programs (NSPs). International Journal of Drug Policy. doi:10.1016/jdrugpo.2010.03.007.
50. Sword W., Jack S., Niccols A., Milligan K., Henderson J., Thabane L. Integrated programs for women with substance use issues and their children: A qualitative meta-synthesis of processes and outcomes. Harm Reduction Journal 2009, 6(32). doi:10.1186/1477-7517-6-32.
51. Toumbourou J. Family involvement in illicit drug treatment?. Drug and Alcohol Review 1994, 13:385-392.
52. Velleman R., Templeton L., Copello A. The role of the family in preventing and intervening with substance use and misuse: A comprehensive review of family interventions, with a focus on young people. Drug and Alcohol Review 2005, 24:93-109.
53. Walsh N., Gibbie T., Higgs P. The development of peer educator-based harm reduction programmes in Northern Vietnam. Drug and Alcohol Review 2008, 27:200-203.
54. Wilke D., Kamata A., Cash S. Modeling treatment motivation in substance-abusing women and children. Child Abuse and Neglect 2005, 29:1313-1323.